UAE Ministry Grants Patent for Groundbreaking COVID-19 Stem Cell Therapy
Abu Dhabi, UAE – The United Arab Emirates’ Ministry of Economy has officially granted a patent for an innovative stem cell treatment developed to combat the novel Coronavirus. This significant intellectual property milestone underscores the nation’s commitment to advancing medical research and development within the region.
The patented treatment, spearheaded by a team of doctors and researchers at the Abu Dhabi Stem Cell Center (ADSCC), involves a unique process. It entails extracting a patient’s own stem cells from their blood, activating them, and then reintroducing them into the body. Early reports indicate promising results from initial clinical trials focused on the safety of the treatment.
According to reports from early May 2020, the initial phase of clinical trials successfully demonstrated the safety of the treatment, with no immediate adverse complications reported by individuals who received it. The therapeutic effect is hypothesized to involve the regeneration of lung cells and the modulation of immune system responses, preventing an overreaction to the COVID-19 infection. Trials to determine the full efficacy of the treatment remain ongoing.
The granting of this patent by a key government body like the Ministry of Economy highlights the robust legal framework in the UAE that supports and protects intellectual property rights for groundbreaking scientific advancements. This development is expected to bolster the UAE’s position as a hub for medical innovation and research, with significant implications for public health and the commercialisation of advanced medical treatments.